A Study of Efficacy and Safety of IBI3011 in Subjects With Acute Gouty Arthritis

by | Sep 25, 2026 | Clinical Trials | 0 comments

​ Conditions: Acute Gouty Arthritis

Interventions: Drug: Compound Betamenth Group; Drug: IBI3011 GROUP

Sponsors: Innovent Biologics (Suzhou) Co. Ltd.

Not yet recruiting Conditions: Acute Gouty Arthritis
Interventions: Drug: Compound Betamenth Group; Drug: IBI3011 GROUP
Sponsors: Innovent Biologics (Suzhou) Co. Ltd.
Not yet recruiting 

Submit a Comment

Your email address will not be published. Required fields are marked *